Houston Chronicle Sunday

Boosters fly under the radar

Survey finds half of adults have heard little or nothing about new COVID shots

- By Jan Hoffman

The new, redesigned COVID booster, which protects against omicron and its extremely contagious subvariant­s, appears to have a visibility problem.

Federal authoritie­s authorized the shot at the end of August, but by mid- to late September, nearly half of adults had heard little or nothing about it, according to a report by the Kaiser Family Foundation, based on the latest of its monthly surveys about attitudes toward the COVID vaccines.

That could have troubling implicatio­ns. The Biden administra­tion has been touting the booster as a means of warding off a fresh fall or winter surge of the virus.

“America is not rushing out to get the new booster,” said Drew Altman, the president of the Kaiser Family Foundation. “Most are only dimly aware of it, which is not surprising in a country that seems to have mostly moved on.” He added, “The exception may be older folks, who are at greater risk and early on are more interested in the new booster.”

The survey was conducted Sept. 15-26, online and by telephone, among a nationally representa­tive sample of 1,534 adults.

Since the first shots were rolled out, people 65 and older, who are the most vulnerable to COVID complicati­ons, have been the most compliant with getting the vaccine. They also displayed the broadest awareness of the new booster, the

survey found, with almost half reporting either having already received the new dose or aiming to get it “as soon as possible.” Nearly onethird of adults overall said they had planned to get it soon as well.

Confusion over eligibilit­y seemed widespread, according to the survey.

The Food and Drug Administra­tion authorized the new booster made by Pfizer and BioNTech for fully vaccinated people as young as 12 and the new Moderna booster for those 18 and older. But among fully vaccinated adults ages 30 and younger, 43 percent percent said they were unsure of whether the dose had been approved for them, and an additional 19 percent said they did not believe it had been.

Mary Politi, a professor in the Division of Public Health Sciences at the Washington University School of Medicine, said Americans had been experienci­ng COVID informatio­n overload and, as a consequenc­e, decision-making fatigue. One way to overcome both, she said, “is to keep informatio­n simple, clear and consistent.”

She added, “Unfortunat­ely, the informatio­n coming from various sources has often been conflictin­g, with uncertain, unclear or changing guidelines.”

Older adults were also better informed about their booster eligibilit­y status. Among those 65 and older, more than half knew the booster was recommende­d, as did nearly half of those ages 50-64.

While the Centers for Disease Control and Prevention recommends that fully vaccinated people 12 and older get the updated booster, it urges those 50 and older in particular to get it.

The report, which also looked at parents’ views of the vaccine, found that there had been a modest uptick in vaccinatio­n among the youngest children since July, when COVID vaccines for those ages 6 months to 4 years received emergency authorizat­ion. At the time, scarcely 7 percent of parents said they intended to get their children vaccinated; that percentage has risen to 19 percent, or nearly 1 in 5 parents.

But more parents are refusing the vaccine for their children, too. Now 53 percent of parents of children ages 6 months to 4 years say they will “definitely not” let their children get the shots. Last January, 26 percent held that view.

While about 60 percent of parents said their children ages 12-17 had been vaccinated, about 30 percent of parents with children in that age group said their children would definitely not get the COVID vaccine.

Overall, 77 percent of respondent­s said they had gotten at least one dose of the COVID vaccine, with nearly half of those saying they had received at least one booster. But 23 percent said they were not vaccinated, and nearly all of that group said they would “definitely not” get the shot.

 ?? Hannah Beier/Bloomberg file ?? A health care worker prepares a booster dose of the Pfizer-BioNTech COVID-19 shot at a vaccine clinic in Lansdale, Pa.
Hannah Beier/Bloomberg file A health care worker prepares a booster dose of the Pfizer-BioNTech COVID-19 shot at a vaccine clinic in Lansdale, Pa.
 ?? Jamie Kelter Davis/New York Times file ?? A nurse prepares a COVID-19 booster shot at a vaccinatio­n site in Maywood, Ill. The new, redesigned booster protects against omicron and its subvariant­s.
Jamie Kelter Davis/New York Times file A nurse prepares a COVID-19 booster shot at a vaccinatio­n site in Maywood, Ill. The new, redesigned booster protects against omicron and its subvariant­s.

Newspapers in English

Newspapers from United States